A Closer at TELUS’ (TSX:T) Healthcare Venture

TELUS’ (TSX:T)(NYSE:TU) ability to deploy capital in a market that is aching for disruption should yield great results for investors over the long-run, according to Vishesh Raisinghani.

| More on:
Man making notes on graphs and charts

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

What does wireless internet have to do with healthcare? At the moment, not much. Broadband penetration and 4G technology have helped connect billions of people, but they haven’t had any noticeable impact on their health and well-being. Last year, Vancouver-based telecommunications giant TELUS (TSX:T)(NYSE:TU) decided to change that.

The company spent $100 million to acquire a chain of 30 boutique corporate and employee health clinics across Canada. It’s also partnered with UK-based virtual healthcare technology provider Babylon and deployed $5 million to create a national network of mobile clinics.

These partnerships help TELUS Health get corporate subscribers to its premium clinics across the country, allow elderly patients to interact with a registered physician via an app on their phone, and deliver critical care through a network of modified vans that act as clinics-on-wheels across the region. It’s still early days, but the overarching theme of innovative and premium health solutions is already apparent.

TELUS Health is perhaps the only example of an established telecom company entering the healthcare space. It’s an unexpected and seemingly odd move, but on closer examination, the strategy comes across as a clever way to establish a foothold in the next frontier of digital innovation.

Healthcare, by all measures, is ripe for disruption. The costs of private care have far exceeded the rate of core inflation, and the quality or accessibility of healthcare hasn’t noticeably improved. According to the 2019 Global Medical Trend Report, the cost of healthcare in Canada is expected to rise 6% in 2019, while inflation remains at 2.1%. In other words, health costs are going up at triple the rate of everything else.

This disconnect makes the healthcare industry in North America, and Canada in particular, ripe for disruption, and many Canadians seem to agree. A recent study by the Canadian Medical Association found that 70% of Canadians would take advantage of virtual physician visits. 75% believe technology can help solve systemic issues in the health industry.

With this in mind, TELUS’ healthcare ventures seem ahead of the curve. The subsidiary is targeting the top-end of a market that could soon be redefined with cutting-edge technologies.

The services they offer, including virtual care appointments, private and secure personal health records, mental health applications, mobile health delivery and emergency response tools, seem tailored for large-scale enterprises and high-income seniors. 

For example, part of their network now includes four luxury clinics in British Columbia and Alberta that serve business executives and employees covered under business health programs. Annual membership fees range from $3,500 to $4,500. High-end health services like these are a way to generate high-margin and recession-proof cash flow from recurring income streams.

The business model is further augmented by the fact that TELUS Health will harness medical data to develop artificial intelligence solutions for doctors and clinics on its network. The company could build a robust competitive edge if it collects and leverages this data before the sector gets competitive.

Bottom line

I think the strategy to diversify into healthcare is genius. The natural synergies between health tech and telecoms aren’t apparent just yet, but TELUS’ ability to deploy capital in a market that is aching for disruption should yield great results for investors over the long-run.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no position in the companies mentioned.   

More on Dividend Stocks

growing plant shoots on stacked coins
Dividend Stocks

5 Dividend Stocks to Buy With Yields Upwards of 5%

These five companies all earn tonnes of cash flow, making them some of the best long-term dividend stocks you can…

Read more »

funds, money, nest egg
Dividend Stocks

TFSA Investors: 3 Stocks to Start Building an Influx of Passive Income

A TFSA is the ideal registered account for passive income, as it doesn't weigh down your tax bill, and any…

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

3 of the Safest Dividend Stocks in Canada

Royal Bank of Canada stock is one of the safest TSX dividend stocks to buy. So is CT REIT and…

Read more »

Growing plant shoots on coins
Dividend Stocks

1 of the Top Canadian Growth Stocks to Buy in February 2023

Many top Canadian growth stocks represent strong underlying businesses, healthy financials, and organic growth opportunities.

Read more »

stock research, analyze data
Dividend Stocks

Wherever the Market Goes, I’m Buying These 3 TSX Stocks

Here are three TSX stocks that could outperform irrespective of the market direction.

Read more »

woman data analyze
Dividend Stocks

1 Oversold Dividend Stock (Yielding 6.5%) to Buy This Month

Here's why SmartCentres REIT (TSX:SRU.UN) is one top dividend stock that long-term investors should consider in this current market.

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Dividend Stocks

Better TFSA Buy: Enbridge Stock or Bank of Nova Scotia

Enbridge and Bank of Nova Scotia offer high yields for TFSA investors seeking passive income. Is one stock now undervalued?

Read more »

Golden crown on a red velvet background
Dividend Stocks

2 Top Stocks Just Became Canadian Dividend Aristocrats

These two top Canadian Dividend Aristocrats stocks are reliable companies with impressive long-term growth potential.

Read more »